Correlation between IL-36α and IL-17 and Activity of the Disease in Selected Autoimmune Blistering Diseases

Correlation between IL-36α and IL-17 and Activity of the Disease in Selected Autoimmune Blistering Diseases

Dermatitis herpetiformis (DH), bullous pemphigoid (BP), and pemphigus vulgaris (PV) are autoimmune bullous skin conditions with eosinophilic and neutrophilic infiltrations. While cytokines are crucial for the affinity and activation of different leukocyte cells in the inflammation and blister format...

Full description

Bibliographic Details
Main Authors:	Agnieszka Żebrowska, Anna Woźniacka, Katarzyna Juczyńska, Kamila Ociepa, Elżbieta Waszczykowska, Izabela Szymczak, Rafał Pawliczak
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	Mediators of Inflammation
Online Access:	http://dx.doi.org/10.1155/2017/8980534

Similar Items

Lupus erythematosus panniculitis resistant to standard treatment, complicated with macrophage activation syndrome
by: Katarzyna Juczynska, et al.
Published: (2017-05-01)

Autoimmune Blistering Diseases
Published: (2020)

The Role of IL-36 in the Pathophysiological Processes of Autoimmune Diseases
by: Wen-jian Chen, et al.
Published: (2021-10-01)

Editorial: Autoimmune Blistering Diseases
by: Cezary Kowalewski, et al.
Published: (2020-07-01)

AUTOIMMUNE EPIDERMAL BLISTERING DISEASES
by: Ana Maria Abreu Velez, et al.
Published: (2013-11-01)

Diagnosis of Autoimmune Blistering Diseases
by: Mareike Witte, et al.
Published: (2018-11-01)

IL-17 Expression in Dermatitis Herpetiformis and Bullous Pemphigoid
by: Agnieszka Zebrowska, et al.
Published: (2013-01-01)

Tissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases
by: Agnieszka Zebrowska, et al.
Published: (2015-01-01)

Diseases presenting with vesicular and erosive lesions of oral mucous membranes
by: Kamila Ociepa, et al.
Published: (2017-11-01)

Current perspectives on the role of IL-17 in autoimmune disease
by: Hisakata Yamada
Published: (2010-06-01)

Drug reaction with eosinophilia and systemic symptoms associated with carbamazepine (DRESS syndrome) – case report and literature review
by: Kamila Ociepa, et al.
Published: (2016-10-01)

Dermatomyositis in patients with autoimmune blistering diseases
by: Aikaterini Patsatsi, et al.
Published: (2019-09-01)

The Role of IL-17 and Related Cytokines in Inflammatory Autoimmune Diseases
by: Taku Kuwabara, et al.
Published: (2017-01-01)

Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis
by: Ewa Robak, et al.
Published: (2019-04-01)

AUTOIMMUNE BASEMENT MEMBRANE AND SUBEPIDERMAL BLISTERING DISEASES
by: Ana Maria Abreu Velez, et al.
Published: (2013-11-01)

Psychosocial impact of inherited and autoimmune blistering diseases
by: Swaranjali V. Jain, B Med Sci (Hons) MD, et al.
Published: (2018-03-01)

Autoimmune blistering diseases in females: a review
by: Cathy Y. Zhao, MBBS, MMed, et al.
Published: (2015-02-01)

Anti-Desmocollin Autoantibodies in Autoimmune Blistering Diseases
by: Xavier Bosch-Amate, et al.
Published: (2021-09-01)

Regulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAs
by: Deena eKhan, et al.
Published: (2015-07-01)

Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis
by: K. Juczynska, et al.
Published: (2017-01-01)

Genetics and Omics Analysis of Autoimmune Skin Blistering Diseases
by: Michael Olbrich, et al.
Published: (2019-10-01)

IMMUNOHISTOCHEMISTRY VERSUS IMMUNOFLUORESENCE IN THE DIAGNOSIS OF AUTOIMMUNE BLISTERING DISEASES
by: Ana Maria Abreu Velez, et al.
Published: (2013-11-01)

Therapeutic Potential of IL-17-Mediated Signaling Pathway in Autoimmune Liver Diseases
by: Haiyan Zhang, et al.
Published: (2015-01-01)

Granzyme B inhibition reduces disease severity in autoimmune blistering diseases
by: Sho Hiroyasu, et al.
Published: (2021-01-01)

The effects of autoimmune blistering diseases on work productivity: A review
by: Esther Q. Wang, et al.
Published: (2018-09-01)

The contribution of IL-17 to the development of autoimmunity in psoriasis
by: Masutaka Furue, et al.
Published: (2019-08-01)

Development of IL-17A-associated autoimmunity
by: Hornsby, E.
Published: (2010)

P40 IL-17F PROMOTES TISSUE INJURY IN AUTOIMMUNE KIDNEY DISEASES
by: H.J. Paust, et al.
Published: (2016-11-01)

Skin Barrier and Autoimmunity—Mechanisms and Novel Therapeutic Approaches for Autoimmune Blistering Diseases of the Skin
by: Natalie E. Stevens, et al.
Published: (2019-05-01)

Dual inhibition of IL-17A and IL-17F in psoriatic disease
by: Helena Iznardo, et al.
Published: (2021-08-01)

Role of the IL23/IL17 Pathway in Crohn’s Disease
by: Heike Schmitt, et al.
Published: (2021-03-01)

Pivotal Roles of T-Helper 17-Related Cytokines, IL-17, IL-22, and IL-23, in Inflammatory Diseases
by: Ning Qu, et al.
Published: (2013-01-01)

Serum Levels of IL-33 and Correlation with IL-4, IL-17A, and Hypergammaglobulinemia in Patients with Autoimmune Hepatitis
by: Ma Liang, et al.
Published: (2018-01-01)

Editorial: The IL-17 Cytokine Family in Tissue Homeostasis and Disease
by: Nicola I. Lorè, et al.
Published: (2021-02-01)

Role of the IL-23/IL-17 Pathway in Rheumatic Diseases: An Overview
by: Claudia Schinocca, et al.
Published: (2021-02-01)

The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis
by: Stefania Madonna, et al.
Published: (2019-07-01)

Specific Inhibition of Complement Activation Significantly Ameliorates Autoimmune Blistering Disease in Mice
by: Sidonia Mihai, et al.
Published: (2018-03-01)

IgG/IgA-pemphigus — extremely rare blistering autoimmune diseases
by: Arfenya E. Karamova, et al.
Published: (2020-03-01)

FGF2 cooperates with IL-17 to promote autoimmune inflammation
by: Xinrui Shao, et al.
Published: (2017-08-01)

Increased serum IL-36β and IL-36γ levels in patients with neuromyelitis optica spectrum disorders: association with disease activity
by: Chun-Sheng Yang, et al.
Published: (2019-08-01)